Biomotion Sciences - Ordinary Shares Share · KYG1281K1067 · SLXN (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of Biomotion Sciences - Ordinary Shares

No Price

01.05.2026 20:52

Current Prices from Biomotion Sciences - Ordinary Shares

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	SLXN	USD	01.05.2026 20:52	0,60 USD	-0,01 USD -2,24 %
IEX	SLXN	USD	01.05.2026 19:26	0,62 USD	0,007 USD +1,21 %

Company Profile for Biomotion Sciences - Ordinary Shares Share

Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel.